RedTram News Search Engine
Русский  English Українська  Français  Polski  Deutsch  Italiano  Español  中文   
24 July 2008 year (time zone GMT 00:00)  Number of sources in English: 4603
Navigating the themes
Navigating the regions
All Themes State & Community Mass Media World Asia
Mass Media (Asia) RSS 2.0

Nath asks US to offer 'real' cuts in subsidy

24.07.2008 01:12    rediff.com
The US on Tuesday made an offer to reduce its overall trade distorting subsidy to $15 billion. India's commerce and industry minister on Wednesday rejoined the crucial negotiations to break the Doha deadlock after his government won a confidence vote


Indian cities become costlier for expats

24.07.2008 01:12    rediff.com
Strengthening rupee and growing aspirational demand has made four Indian cities -- Delhi, Mumbai, Bangalore and Chennai -- increasingly expensive for expatriates to live in, a latest global survey says.

Trust vote: News channels' ratings zoom

24.07.2008 01:11    rediff.com
The live telecast of Tuesday's trust vote in Parliament saw the combined market share of Hindi news channels go up by 48 per cent, while those of the English news channels increased by 17 per cent compared with the previous

Shield consumers from tariff hike for 1 yr: Trai

24.07.2008 01:11    rediff.com
Consumers may now be insulated from any tariff increase for a period of 12 months if the recommendations made in a consultation paper of the Telecom Regulatory Authority of India (Trai) are accepted. At the moment, consumers have a protection

India Inc bets big on N-power

24.07.2008 01:11    rediff.com
Indian companies led by Anil Ambani's Reliance Power (RPower), Nuclear Power Corporation of India (NPCIL) and Bharat Heavy Electricals (BHEL) plan to invest over Rs 100,000 crore in the next five years to expand their presence in the nuclear energy

Govt likely to relax human trial norms

24.07.2008 01:11    rediff.com
Raising hopes for multinational pharmaceutical research companies, India has begun a consultation on steps to ease the existing clinical trial norms to allow Indian volunteers to be subjected to first-in-human phase I studies of potential medicines developed abroad.

1